COVID-19
RFK Jr. pauses $240 million contract for new ‘oral COVID vaccine’
From LifeSiteNews
For his first major action since taking office just two weeks ago, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has issued a 90-day stop-work order to American biotech company Vaxart Inc., which had been contracted during the Biden administration to develop a new “oral COVID-19 vaccine.”
Kennedy’s order came just as 10,000 individuals were scheduled to begin clinical trials on Monday.
HHS will utilize the 90-day hiatus to review Vaxart’s initial findings to determine the future of the human trials and continued drug development.
Approximately $460 million had been allotted to Vaxart by HHS to develop its new COVID-19 “vaccine,” of which $240 million had been authorized for the preliminary study, according to a report by Fox News Digital, which broke the story.
“While it is crucial that the Department [of] Health and Human Services support pandemic preparedness, four years of the Biden administration’s failed oversight have made it necessary to review agreements for vaccine production, including Vaxart’s,” Kennedy told Fox News Digital.
“I look forward to working with Vaxart and medical experts to ensure this work produces safe, effective, and fiscal-minded vaccine technology,” added Kennedy.
“If anyone was worried that RFK would not address vaccine damage, this is proof he’s only getting started,” declared the producers of the 2022 Died Suddenly film, which questioned the motives behind the development and mandating of the first round of COVID-19 shots and the startling number of deaths attributed to them.
There appears to be plenty of justification for pausing and even terminating Vaxart’s continued development of its “oral COVID-19 vaccine”
According to a report by The Defender’s John-Michael Dumais and published by LifeSiteNews in June, “Vaxart’s pill, VXA-CoV2-1, uses an adenovirus vector to infect epithelial cells in the lower small intestine. The vaccine delivers the genetic material to create the spike protein. The company boasts that a special coating allows the oral pill to survive the low pH in the stomach.”
“Johnson & Johnson’s (J&J) and AstraZeneca’s COVID-19 vaccines also used adenovirus vectors,” noted Dumais, who explained:
The use of J&J’s vaccine was paused in April 2021 due to reports of thrombosis with thrombocytopenia syndrome (TTS), a severe blood clotting disorder. In July 2021, the FDA warned about the risk of Guillain-Barré syndrome with the J&J vaccine after approximately 100 cases were reported among 12.8 million vaccine recipients. With existing doses of the J&J vaccine having expired in May 2023, the vaccine is no longer in use.
AstraZeneca’s COVID-19 vaccine also caused blood clots, resulting in temporary pauses in its use in several countries. With declining demand, it was also removed from the market in May 2023.
Vaxart’s oral COVID-19 development project is part of the Biden administration’s $4.7 billion Project NextGen initiative, launched in 2023 to accelerate the development of new COVID “vaccines.”
Vaxart’s “vaccine” was funded through a contract with the Biomedical Advanced Research and Development Authority (BARDA), which falls under the umbrella of HHS’s Administration for Strategic Preparedness and Response.
The pausing of Vaxart’s COVID-19 “vaccine” development can be seen as Kennedy’s first important move to fulfill his stated mission as HHS secretary.
Shortly after Robert F. Kennedy Jr. was sworn in as secretary of the Department of Health and Human Services (HHS), President Donald Trump signed an executive order titled Establishing The President’s Make America Healthy Again Commission (MAHA EO) to investigate and address the root causes of America’s escalating health crisis.
Chaired by Kennedy, the commission has four main policy directives to reverse chronic disease: Empower Americans through transparency and open-source data and avoid conflicts of interest in all federally funded health research; prioritize gold-standard research on why Americans are getting sick in all health-related research funded by the federal government; work with farmers to ensure that U.S. food is the healthy, abundant, and affordable; and ensure expanded treatment options and health coverage flexibility for beneficial lifestyle changes and disease prevention.
The MAHA EO came at a time when many Americans have lost trust in the nation’s healthcare system and are increasingly skeptical as to whether they are receiving honest answers about the causes of the country’s health crisis and how to improve it.
From LifeSiteNews
A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna
A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.
The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:
Study Overview
- Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
- Intervention: Two doses of either:
- BNT162b2 (Pfizer-BioNTech)
- mRNA-1273 (Moderna)
- Follow-up Duration: 12 months after second dose.
- Comparison: Head-to-head between Pfizer vs. Moderna recipients.
- Main Outcomes:
- All-cause mortality
- Cardiovascular mortality
- COVID-19 mortality
- Non-COVID-19 mortality
All-cause mortality
Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.
- Pfizer Risk: 847.2 deaths per 100,000 people
- Moderna Risk: 617.9 deaths per 100,000 people
- Risk Difference:
➔ +229.2 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.37 (i.e., 37% higher mortality risk with Pfizer) - Odds Ratio (Adjusted):
➔ 1.384 (95% CI: 1.331–1.439)
Cardiovascular mortality
Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.
- Pfizer Risk: 248.7 deaths per 100,000 people
- Moderna Risk: 162.4 deaths per 100,000 people
- Risk Difference:
➔ +86.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.53 (i.e., 53% higher cardiovascular mortality risk) - Odds Ratio (Adjusted):
➔ 1.540 (95% CI: 1.431–1.657)
COVID-19 mortality
Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.
- Pfizer Risk: 55.5 deaths per 100,000 people
- Moderna Risk: 29.5 deaths per 100,000 people
- Risk Difference:
➔ +26.0 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.88 (i.e., 88% higher COVID-19 mortality risk) - Odds Ratio (Adjusted):
➔ 1.882 (95% CI: 1.596–2.220)
Non-COVID-19 mortality
Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.
- Pfizer Risk: 791.6 deaths per 100,000 people
- Moderna Risk: 588.4 deaths per 100,000 people
- Risk Difference:
➔ +203.3 deaths per 100,000 (Pfizer excess) - Risk Ratio (RR):
➔ 1.35 (i.e., 35% higher non-COVID mortality risk) - Odds Ratio (Adjusted):
➔ 1.356 (95% CI: 1.303–1.412)
Biological explanations
The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:
The paper hypothesizes differences between Pfizer and Moderna may be due to:
- Different lipid nanoparticle compositions
- Differences in manufacturing, biodistribution, or storage conditions
Final conclusion
Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.
Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.
As the authors conclude:
These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.
Epidemiologist and Foundation Administrator, McCullough Foundation
Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.
Reprinted with permission from Focal Points.
Fr0m LifeSiteNews
A Department of Health memo warns that Canada’s Vaccine Injury Support Program will exceed its $75 million budget due to high demand, with $16 million already paid out.
COVID vaccine injury payments are expected to go over budget, according to a Canadian Department of Health memo.
According to information published April 28 by Blacklock’s Reporter, the Department of Health will exceed their projected payouts for COVID vaccine injuries, despite already spending $16 million on compensating those harmed by the once-mandated experimental shots.
“A total $75 million in funding has been earmarked for the first five years of the program and $9 million on an ongoing basis,” the December memo read. “However the overall cost of the program is dependent on the volume of claims and compensation awarded over time, and that the demand remains at very high levels.”
“The purpose of this funding is to ensure people in Canada who experience a serious and permanent injury as a result of receiving a Health Canada authorized vaccine administered in Canada on or after December 8, 2020 have access to a fair and timely financial support mechanism,” it continued.
Canada’s Vaccine Injury Support Program (VISP) was launched in December 2020 after the Canadian government gave vaccine makers a shield from liability regarding COVID-19 jab-related injuries.
While Parliament originally budgeted $75 million, thousands of Canadians have filed claims after received the so-called “safe and effective” COVID shots. Of the 3,060 claims received to date, only 219 had been approved so far, with payouts totaling over $16 million.
Since the start of the COVID crisis, official data shows that the virus has been listed as the cause of death for less than 20 kids in Canada under age 15. This is out of six million children in the age group.
The COVID jabs approved in Canada have also been associated with severe side effects such as blood clots, rashes, miscarriages, and even heart attacks in young, healthy men.
Additionally, a recent study done by researchers with Canada-based Correlation Research in the Public Interest showed that 17 countries have found a “definite causal link” between peaks in all-cause mortality and the fast rollouts of the COVID shots as well as boosters.
Interestingly, while the Department of Health has spent $16 million on injury payouts, the Liberal government spent $54 million COVID propaganda promoting the vaccine to young Canadians.
The Public Health Agency of Canada especially targeted young Canadians ages 18-24 because they “may play down the seriousness of the situation.”
The campaign took place despite the fact that the Liberal government knew about COVID vaccine injuries, according to a secret memo.
Premier Danielle Smith responds to election of Liberal government
Top Used Ford SUVs for Families and Adventurers
Canada is squandering the greatest oil opportunity on Earth
Net Zero by 2050: There is no realistic path to affordable and reliable electricity
-
Business2 days agoTrump’s bizarre 51st state comments and implied support for Carney were simply a ploy to blow up trilateral trade pact
-
Business2 days agoChina’s economy takes a hit as factories experience sharp decline in orders following Trump tariffs
-
Agriculture1 day agoLiberal win puts Canada’s farmers and food supply at risk
-
International2 days agoJavier Millei declassifies 1850+ files on Nazi leaders in Argentina
-
COVID-192 days ago
Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna
-
Alberta1 day agoAlberta’s future in Canada depends on Carney’s greatest fear: Trump or Climate Change
-
Frontier Centre for Public Policy2 days agoTrust but verify: Why COVID-19 And Kamloops Claims Demand Scientific Scrutiny
-
International1 day agoNigeria, 3 other African countries are deadliest for Christians: report